Lars Velten

larsplus.bsky.social

04 September 2026 19:14

It's been preprint week! Joe's great Perturb-seq story "back-to-back" with our single cell AML atlas (led by @simonhaas.bsky.social). 🤒: www.biorxiv.org/content/10.6... 🧬: www.biorxiv.org/content/10.6... These two apparently very different stories were posted back to back because of a surprise 😮🧵:

Nature Cell Biology

natcellbio.nature.com

04 September 2026 19:11

☕Single-cell transplantations of long-term HSCs, in-depth phenotyping and mathematical modeling identify reconstitution kinetics as a unifying metric of HSC potency and extrinsic regulation as a driver of lineage bias. @simonhaas.bsky.social @milsommick.bsky.social www.nature.com/articles/s41...

Lars Velten

larsplus.bsky.social

04 September 2026 19:08

Congratulations to the first authors of both studies - @joebowness.bsky.social and Jan Barinka (from @simonhaas.bsky.social lab). I'm very priviliged to work with scientists like you. Data and code is public. (5/5)

Max Delbrück Center

mdc-berlin.bsky.social

25 June 2026 05:28

Imagine testing cancer therapies on patient-derived organoids before treatment begins. At the #mdcBerlin Bioengineering Symposium, researchers will discuss how bioengineering is bringing medicine closer to that future. 🗓️ July 6 | Berlin-Buch More details: 👉 www.mdc-berlin.de/news/press/j... 👈

Max Delbrück Center

mdc-berlin.bsky.social

25 June 2026 05:27

From designing therapeutic RNA molecules to creating avatars of pediatric brain tumors: Uwe Ohler and Gaetano Gargiulo have been awarded ERC Advanced Grants. The two MDC researchers will each receive up to €2.5 million over five years. More: 👉 www.mdc-berlin.de/news/news/er... 👈 #mdcBerlin